论文部分内容阅读
目的:探讨布地奈德治疗慢性阻塞性肺疾病的临床效果。方法:回顾性分析本院2010年2月￣2012年2月收治的110例慢性阻塞性肺疾病患者的临床资料,随机分为观察组(55例)与对照组(55例)。观察组给予超声雾化吸入布地奈德与沐舒坦治疗,对照组给予甲泼尼龙治疗,10d后比较两组患者的治疗效果。结果:观察组总有效率为94.55%,对照组总有效率为80.00%,两组患者治疗总有效率比较差异有显著性(X2=5.553,P<0.05)。结论:布地奈德与沐舒坦联合超声雾化吸入治疗慢性阻塞性肺疾病效果显著,不良反应少,安全性高,值得临床推广应用。
Objective: To investigate the clinical efficacy of budesonide in the treatment of chronic obstructive pulmonary disease. Methods: The clinical data of 110 patients with chronic obstructive pulmonary disease admitted from February 2010 to February 2012 in our hospital were retrospectively analyzed. They were randomly divided into observation group (55 cases) and control group (55 cases). The observation group was treated with inhalation of budesonide and mucosolvan by ultrasonic atomization. The control group was treated with methylprednisolone. The treatment effect was compared between the two groups after 10 days. Results: The total effective rate was 94.55% in the observation group and 80.00% in the control group. The total effective rate of the two groups was significantly different (X2 = 5.553, P <0.05). Conclusion: Budesonide and ambroxol combined with ultrasonic atomization inhalation for the treatment of chronic obstructive pulmonary disease have significant effects, less adverse reactions, high safety, and worthy of clinical application.